Navigation Links
Analyte Health Appoints Lawrence Leisure to its Advisory Board

CHICAGO, Jan. 13, 2014 /PRNewswire/ -- Analyte Health ( announced today that Lawrence Leisure has joined its Advisory Board. Mr. Leisure comes with a wealth of experience within the health and managed care industries, and currently serves as a Life Sciences partner at Kleiner Perkins Caufield & Byers. He has held consulting leadership positions at Ingenix Consulting where he led their Payer & Employer Market Group, Accenture where he was the Global Managing Partner for the Health Vertical, and Towers Perrin where he led the Managed Care practice. In these various roles he also served as client partner to many of the largest US health plans and pharmacy benefit management organizations as well as a number of the largest global employers.

Mr. Leisure joins the Analyte Health Advisory Board and will be involved in providing strategic insights for new channel development, medical ecosystem partnerships, and the continued expansion of the company's Diagnostic Triage platform to other health conditions. "I have been invested in the acceleration of innovation in health care for many years. Analyte Health is positioned to be a leader in diagnostic triage and I am excited to work with the team to further develop its reach and impact," said Mr. Leisure.

Sridhar Murthy, CEO of Analyte Health said, "We are excited to welcome Lawrence Leisure to our Advisory Board. His wealth of experience and industry knowledge will provide an invaluable resource as we find new and effective ways to effectively and efficiently diagnose diseases early, and to triage these patients quickly to the appropriate care."

About Analyte Health, Inc.

Analyte Health is a diagnostic triage company. Its mission is to provide convenient access to education, diagnostic testing, personalized results and recommendations to consumers through its Online Clinics. Analyte Health offers access to healthcare via the phone and the web to a national team of doctors and partner diagnostic labs. Over 125,000 patients have trusted Analyte Health to deliver convenient and private STD testing and care. More information about the company is available at

Forward-Looking Statements
Analyte Health, Inc. is a privately held company. This press release may be deemed to contain forward-looking statements, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected benefits to consumers from using Analyte Health's services. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual future events or results due to a variety of risks and uncertainties, including, among other things, the potential impact of regulatory and third party payer developments in the field of telehealth and STD testing, general business and economic conditions, changes in arrangements with vendors or suppliers, and costs or delays in obtaining or maintaining regulatory approvals and licenses. Any forward-looking statements in this release are based on limited information currently available to Analyte Health, which is subject to change, and Analyte Health will not necessarily update the information.

SOURCE Analyte Health, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Diplomats CEO and CFO to co-present at J.P. Morgans Annual Healthcare Conference
2. Practice Fusion Partners with Healthagens Practice iQ to Help Physician Groups Perform as ACOs
3. Halozyme Therapeutics Provides an Update on Anticipated Milestones for 2014 at the 32nd Annual J. P. Morgan Healthcare Conference
4. Seres Health Announces Interim Clinical Data for SER-109 in Recurrent C. difficile
5. Concordia Healthcare Corp. announces FDA agreement on Special Protocol Assessment for Phase 3 Clinical trial on new therapy to treat perihilar cholangiocarcinoma
6. St. Vincent Health Selects Acupera to Improve Population Health and Team-based Care Delivery
7. Haemonetics Announces Signing of Supply Agreement with HemeXcel at J.P. Morgan Health Care Conference
8. Covance to Present at the 32nd Annual J. P. Morgan Healthcare Conference
9. Regulatory Oversight Significantly Impacting Spending at Benchmarked Healthcare Companies
10. WuXi PharmaTech Provides Update of 2013 Financial Guidance, to Present at J.P. Morgan Healthcare Conference
11. Rigel Will Present Clinical Product Portfolio Update at J.P. Morgan Healthcare Conference
Post Your Comments:
(Date:11/27/2015)... ) ... "2016 Global Tumor Marker Testing Market: Supplier ... Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive ... offering. --> ) has ... Global Tumor Marker Testing Market: Supplier Shares ...
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... nuevo enfoque combina la inmunoterapia con la terapia fotodinámica ... Clinical Cancer Research . --> Clinical ...
(Date:11/26/2015)... , November 26, 2015 ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... has found that immunotherapy can be efficiently combined ...
Breaking Medicine Technology:
(Date:11/27/2015)... , ... November 27, 2015 , ... Avid collector, Andrew ... Arbor Michigan boxing style concert posters. This is one of Joplin's most famous and ... House at the University of Michigan in Ann Arbor. The According to Hawley, "It ...
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think Thanksgiving, they also ... buy during the Black Friday and Cyber Monday massage chair sales to ... Internet high and low to find the best massage chair deals, they can see ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... of workshops to discuss bioavailability and the need to integrate dose form selection ... in collaboration with OBN, the membership organization supporting and bringing together the UK’s ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, ... in the 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted ... 8th through Wednesday, November 11th, 2015. The conference was held at the Hawaii ...
(Date:11/26/2015)... ... 2015 , ... Indosoft Inc., developer and distributor of the world-class Asterisk based ... efficiency and reliability. , The new Q-Suite 6 platform is based on the latest ... itself into a specific piece of software for many key components of the suite. ...
Breaking Medicine News(10 mins):